CLINUVEL PHARMACEUTICALS LIMITED

ASX: CUV
Sector
Sector:Health Care
Industry group
Industry:Pharmaceuticals, Biotechnology & Life Sciences

CUV Share Price

CUV chart by TradingView

Latest CUV ASX Announcements

  1. 20 Aug 2026 · 7:07 pmPresentations
    CLINUVEL Annual Results - Investor Webinar
  2. 14 Aug 2026 · 6:16 pmSubstantial Holders
    Becoming a substantial holder
  3. 12 Aug 2026 · 7:12 pmCompany Update
    CLINUVEL's injectable peptide platform
  4. 30 July 2026 · 6:57 pmCompany Update
    Commercial update on vitiligo
  5. 28 July 2026 · 6:56 pmCompany Update
    Update - SCENESSE in vitiligo
  6. 27 July 2026 · 6:48 pmOther
    Notification of cessation of securities - CUV
  7. 23 July 2026 · 7:11 pmCompany Update
    CLINUVEL strategic reorganisation to refocus on U.S. markets
  8. 21 July 2026 · 6:35 pmSecurities Administration
    CLINUVEL's ADS commences trading on Nasdaq
  9. 20 July 2026 · 6:33 pmCompany Administration
    CLINUVEL's ADS to commence trading on Nasdaq
  10. 13 July 2026 · 6:34 pmCompany Update
    SCENESSE approved for EPP in Canada
  11. 2 July 2026 · 9:36 pmCompany Administration
    CLINUVEL confirms terms of CEO's Employment Agreement
  12. 16 June 2026 · 7:06 pmCompany Administration
    CLINUVEL publicly files 20-F to U.S. SEC
  13. 2 June 2026 · 7:26 pmPresentations
    CLINUVEL US Non-Deal Roadshow Presentation
  14. 7 May 2026 · 9:45 pmOther
    Notification regarding unquoted securities - CUV
  15. 28 Apr 2026 · 6:50 pmCompany Administration
    CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
View complete CUV announcement history →